75 related articles for article (PubMed ID: 24612046)
1. Modulation of RTK by sEcad: a putative mechanism for oncogenicity in oropharyngeal SCCs.
Teng X; Ma L; Kyrkanides S; Raja V; Trochesset D; Brouxhon SM
Oral Dis; 2015 Mar; 21(2):185-94. PubMed ID: 24612046
[TBL] [Abstract][Full Text] [Related]
2. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.
Brouxhon SM; Kyrkanides S; Teng X; Athar M; Ghazizadeh S; Simon M; O'Banion MK; Ma L
Oncogene; 2014 Jan; 33(2):225-35. PubMed ID: 23318419
[TBL] [Abstract][Full Text] [Related]
3. Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.
Matsumoto F; Fujimaki M; Ohba S; Kojima M; Yokoyama J; Ikeda K
Head Neck; 2015 Jul; 37(7):977-81. PubMed ID: 24700733
[TBL] [Abstract][Full Text] [Related]
4. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.
Brouxhon SM; Kyrkanides S; Raja V; Silberfeld A; Teng X; Trochesset D; Cohen J; Ma L
Mol Cancer Ther; 2014 Jul; 13(7):1791-802. PubMed ID: 24748654
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab.
Iyer G; Price J; Bourgeois S; Armstrong E; Huang S; Harari PM
BMC Cancer; 2016 Oct; 16(1):773. PubMed ID: 27716204
[TBL] [Abstract][Full Text] [Related]
7. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Liu MD; Wu H; Wang S; Pang P; Jin S; Sun CF; Liu FY
Gene; 2018 Mar; 646():1-7. PubMed ID: 29278769
[TBL] [Abstract][Full Text] [Related]
8. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
Matsumoto F; Ohba S; Fujimaki M; Ikeda K
Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
[TBL] [Abstract][Full Text] [Related]
9. t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.
Lenz G; Hamilton A; Geng S; Hong T; Kalkum M; Momand J; Kane SE; Huss JM
Clin Cancer Res; 2018 Mar; 24(5):1216-1226. PubMed ID: 29180608
[No Abstract] [Full Text] [Related]
10. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
12. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
13. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
14. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
15. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
[TBL] [Abstract][Full Text] [Related]
16. EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma.
Sivarajah S; Kostiuk M; Lindsay C; Puttagunta L; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):1. PubMed ID: 30630536
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy.
Friedrich RE; Hagel C; Bartel-Friedrich S
Anticancer Res; 2010 May; 30(5):1641-3. PubMed ID: 20592355
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma.
Slomiany MG; Black LA; Kibbey MM; Tingler MA; Day TA; Rosenzweig SA
Cancer Lett; 2007 Apr; 248(2):269-79. PubMed ID: 16996205
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
Bozec A; Peyrade F; Milano G
Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
